Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Action of surfactants on the mammal epidermal skin barrier.

Barba C, Semenzato A, Baratto G, Coderch L.

G Ital Dermatol Venereol. 2018 Sep 20. doi: 10.23736/S0392-0488.18.05874-1. [Epub ahead of print]

PMID:
30249078
2.

Synthesis of Ferrofluids Made of Iron Oxide Nanoflowers: Interplay between Carrier Fluid and Magnetic Properties.

Spizzo F, Sgarbossa P, Sieni E, Semenzato A, Dughiero F, Forzan M, Bertani R, Del Bianco L.

Nanomaterials (Basel). 2017 Nov 5;7(11). pii: E373. doi: 10.3390/nano7110373.

3.

Star-like oligo-arginyl-maltotriosyl derivatives as novel cell-penetrating enhancers for the intracellular delivery of colloidal therapeutic systems.

Bersani S, Salmaso S, Mastrotto F, Ravazzolo E, Semenzato A, Caliceti P.

Bioconjug Chem. 2012 Jul 18;23(7):1415-25. doi: 10.1021/bc200666u. Epub 2012 Jul 3.

PMID:
22709433
4.

New association of surfactants for the production of food and cosmetic nanoemulsions: preliminary development and characterization.

Fratter A, Semenzato A.

Int J Cosmet Sci. 2011 Oct;33(5):443-9. doi: 10.1111/j.1468-2494.2011.00652.x. Epub 2011 Apr 21.

PMID:
21507014
5.

New cyclodextrin bioconjugates for active tumour targeting.

Salmaso S, Bersani S, Semenzato A, Caliceti P.

J Drug Target. 2007 Jul;15(6):379-90.

PMID:
17613656
6.

Cyclodextrin/PEG based hydrogels for multi-drug delivery.

Salmaso S, Semenzato A, Bersani S, Matricardi P, Rossi F, Caliceti P.

Int J Pharm. 2007 Dec 10;345(1-2):42-50. Epub 2007 May 23.

PMID:
17597313
7.

Nanotechnologies in protein delivery.

Salmaso S, Bersani S, Semenzato A, Caliceti P.

J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):2736-53. Review.

PMID:
17048478
8.

Preparation and characterization of active site protected poly(ethylene glycol)-avidin bioconjugates.

Salmaso S, Semenzato A, Bersania S, Chinol M, Paganelli G, Caliceti P.

Biochim Biophys Acta. 2005 Oct 30;1726(1):57-66.

PMID:
15964691
9.

Glycosylated macromolecular conjugates of antiviral drugs with a polyaspartamide.

Cavallaro G, Maniscalco L, Caliceti P, Salmaso S, Semenzato A, Giammona G.

J Drug Target. 2004;12(9-10):593-605.

PMID:
15621685
10.

Allergic contact sensitivity in elderly patients.

Piaserico S, Larese F, Recchia GP, Corradin MT, Scardigli F, Gennaro F, Carriere C, Semenzato A, Brandolisio L, Peserico A, Fortina AB; North-East Italy Contact Dermatitis Group.

Aging Clin Exp Res. 2004 Jun;16(3):221-5.

PMID:
15462465
11.

Specific antitumor targetable beta-cyclodextrin-poly(ethylene glycol)-folic acid drug delivery bioconjugate.

Salmaso S, Semenzato A, Caliceti P, Hoebeke J, Sonvico F, Dubernet C, Couvreur P.

Bioconjug Chem. 2004 Sep-Oct;15(5):997-1004.

PMID:
15366952
12.

Synthesis and physicochemical characterization of folate-cyclodextrin bioconjugate for active drug delivery.

Caliceti P, Salmaso S, Semenzato A, Carofiglio T, Fornasier R, Fermeglia M, Ferrone M, Pricl S.

Bioconjug Chem. 2003 Sep-Oct;14(5):899-908.

PMID:
13129392
13.

Poly(hydroxyethylaspartamide) derivatives as colloidal drug carrier systems.

Cavallaro G, Licciardi M, Giammona G, Caliceti P, Semenzato A, Salmaso S.

J Control Release. 2003 Apr 29;89(2):285-95.

PMID:
12711451
14.

Poly(ethylene glycol)-avidin bioconjugates: suitable candidates for tumor pretargeting.

Caliceti P, Chinol M, Roldo M, Veronese FM, Semenzato A, Salmaso S, Paganelli G.

J Control Release. 2002 Sep 18;83(1):97-108.

PMID:
12220842

Supplemental Content

Loading ...
Support Center